Early access experience with VPRIV(®): recommendations for 'core data' collection

Blood Cells Mol Dis. 2011 Aug 15;47(2):140-2. doi: 10.1016/j.bcmd.2010.10.015. Epub 2010 Dec 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Data Collection / standards
  • Enzyme Replacement Therapy / ethics
  • Enzyme Replacement Therapy / methods*
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / pathology
  • Glucosylceramidase / administration & dosage
  • Glucosylceramidase / biosynthesis
  • Glucosylceramidase / therapeutic use*
  • Humans
  • Practice Guidelines as Topic / standards
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / therapeutic use*

Substances

  • Recombinant Proteins
  • Glucosylceramidase
  • Velaglucerase alfa, human